← All themes

Immunotherapy & Oncology

Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.

388 stocks

# Name Holding Trade Value Theme
Stocks
% of
Portfolio
Status
576
Brinker Capital Investments
Brinker Capital Investments
Pennsylvania
$198M -$662K 34 1.51% Reduced
577
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management
California
$198M -$10.8M 3 0.58% Reduced
578
LMR Partners
LMR Partners
United Kingdom
$197M +$37.3M 33 0.74% Increased
579
Horizon Investments
Horizon Investments
North Carolina
$197M +$10.1M 17 2.16% Increased
580
APM
Avidity Partners Management
Texas
$197M +$17.6M 14 31.57% Increased
581
SVCM
Saturn V Capital Management
Texas
$196M +$2.91M 6 28.15% Increased
582
PHS
PFM Health Sciences
California
$196M -$12.3M 17 16.82% Reduced
583
DCP
Davern Capital Partners
New York
$195M +$21.5M 4 33.19% Increased
584
Cincinnati Financial Corp
Cincinnati Financial Corp
Ohio
$194M $0 2 3.7% Maintained
585
Jump Financial
Jump Financial
Illinois
$193M +$46.7M 68 1.55% Increased
586
Fideuram - Intesa Sanpaolo Private Banking
Fideuram - Intesa Sanpaolo Private Banking
$192M -$20M 16 5.77% Reduced
587
PointState Capital
PointState Capital
New York
$192M -$112M 2 2.45% Reduced
588
Vest Financial
Vest Financial
Virginia
$191M -$2.58M 8 2% Reduced
589
Mawer Investment Management
Mawer Investment Management
Alberta, Canada
$190M +$16.9M 2 1.29% Increased
590
Fideuram Asset Management (Ireland)
Fideuram Asset Management (Ireland)
$190M +$172M 16 3.61% Increased
591
Daymark Wealth Partners
Daymark Wealth Partners
Ohio
$188M +$25.7M 12 4.6% Increased
592
OFI Invest Asset Management
OFI Invest Asset Management
France
$188M -$47.8M 9 1.87% Reduced
593
Snyder Capital Management
Snyder Capital Management
California
$188M +$4.98M 1 3.24% Increased
594
Merit Financial Group
Merit Financial Group
Georgia
$187M -$7.77M 33 1.14% Reduced
595
Loring Wolcott & Coolidge Fiduciary Advisors
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$187M -$4.75M 16 1.82% Reduced
596
EC
Elmind Capital
New York
$187M +$8.3M 13 46.93% Increased
597
Bailard
Bailard
California
$187M -$906K 15 3.8% Reduced
598
GGHC
Gilder Gagnon Howe & Co
New York
$186M -$43.3M 8 1.92% Reduced
599
TECP
Trails Edge Capital Partners
Georgia
$186M +$24M 10 29.46% Increased
600
FIS
FCPM III Services
Netherlands
$185M +$29M 6 24.64% Increased